🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🧬 New hope for #PancreaticCancer patients! Teresa Zimmers and team published a study in Journal of Clinical Oncology exploring how to better treat cancer while protecting muscle health. This study is a step toward targeting #Cachexia and improving life during treatment: bit.ly/3YR0PPY

“Our nanoparticles reduce the energy needed for ultrasound treatment by up to 100-fold. This allows short ultrasound pulses to disrupt tumors mechanically, without overheating surrounding tissue.” - Michael Henderson, co-lead author #OHSUResearch: bit.ly/458TDT8

A new way to treat chemotherapy-induced peripheral neuropathy 🏥 Researchers Kerri Winters-Stone and Eric Roeland published a study in Journal of Clinical Oncology on the use of low-intensity vibration to reduce symptoms and improve functioning in cancer survivors with CIPN: bit.ly/3H1l9rK

Great National Cancer Institute news article just published summarizing our NIH funded research. Discovering optimal treatment options for our patients with #GBM #Glioblastoma is critically important. OHSU Knight Cancer Institute OHSU News OHSU Radiology Radiology SNO Jay Bhattacharya, MD, PhD

Register for the town hall to learn more about how to navigate your #asco experience in Chicago next week! OHSU Knight Cancer Institute ASCO ASCO TECAG The ASCO Post

Our new publication is out today in the OnlineFirst section of Blood Cancer Discovery! We explored correlations between monocytic AML, genetics, and survival by leveraging a large international clinical cohort of patients with AML treated with HMA+VEN. aacrjournals.org/bloodcancerdis…

Main clinical take homes: 👉Monocytic AML: enriched for RAS mut. (known), but also NPM1 mut. 👉~40% of monocytic AML cases were RAS wt. 👉 Important to consider genetics and phenotype with VEN tx. 👉Monocytic AML influenced survival dependent on underlying genetic context.

Bulk RNAseq de-convolution demonstrated other genetic combinations associated with monocytic bias, and scDNA+protein analysis provided further clarity on genotype/phenotype relationships for a few select cases (in agreement with published data).

The CME-accredited Best of ASCO 2025 review series is coming to #Portland! Join Dr. Julie Graff and other leading experts at OHSU Knight Cancer Institute to break down the practice-changing abstracts from the 2025 ASCO® Annual Meeting. 🌟Register today: buff.ly/77Q2dmD #MedEd #MedTwitter

Very excited to share our new Nature Communications paper describing machine learning methods for predicting single-cell protein abundance levels in multiplex tissue imaging rdcu.be/em5mR 1/🧵

It was an honor to visit OHSU Knight Cancer Institute and hear about the exciting science going on there, with a highlight of getting to have a really great discussion with a stellar group of students and postdocs. TY for the invitation to share our lab's work on #CancerMetabolism!

"We are working on a promising new therapeutic approach to reduce neuropathy - a debilitating, persistent symptom of chemo. Currently, there are no non-pharmacologic treatment options for patients." - Kerri Winters-Stone on a study published in Journal of Clinical Oncology: bit.ly/3H1l9rK

A new study by Barajas Lab and team used data from 261 patients to build an AI-based model to predict survival from #Glioblastoma and compared brain scans from before and after surgery. They saw the best outcome came from aggressive surgery (via National Cancer Institute): bit.ly/3YZYh29

#Impactful collaborative #Science OHSU News OHSU Radiology Thank you to the NIH National Cancer Institute Jay Bhattacharya, MD, PhD for funding this clinically important research. pubs.rsna.org/doi/10.1148/ra…

🧬 New hope for #PancreaticCancer patients! Teresa Zimmers and team published a study in Journal of Clinical Oncology exploring how to better treat cancer while protecting muscle health. This study is a step toward targeting #Cachexia and improving life during treatment: bit.ly/3YR0PPY

A new way to treat chemotherapy-induced peripheral neuropathy 🏥 Researchers Kerri Winters-Stone and Eric Roeland published a study in Journal of Clinical Oncology on the use of low-intensity vibration to reduce symptoms and improve functioning in cancer survivors with CIPN: bit.ly/3H1l9rK

“For patients and families facing a diagnosis of IDH-wildtype #Glioblastoma, our findings provide new hope. We have strong evidence that more extensive tumor removal can translate to meaningful survival gains.” - Barajas Lab on new #GBM study (National Cancer Institute): bit.ly/3YZYh29